Figure it out or fail: Extracting the value from unstructured data
Organizations may think that more healthcare data means more value, but the complexity of extracting that value can be challenging. Learn why.
Fresh perspectives on clinical terminologies, code mapping, and patient insights from the experts at IMO.
This year, the World Health Organization is celebrating the important role of nurses in modern healthcare. To mark the Year of the Nurse and Midwife, we’re shining the spotlight on our own nursing staff members for a special IMO Q&A blog series.
When the new coronavirus hit US hospitals at the beginning of the year, many institutions halted elective surgical procedures and diverted resources to care for pandemic patients. Now, most operating rooms have reopened their doors, but patient anxiety about coming into contact with COVID-19 is still keeping many away.
A comprehensive webinar on the ICD-10-CM 2021 code updates.
Back in March, new rules mandating how health systems must improve their interoperability methods were published by the Department of Health and Human Services. In a new white paper, IMO’s Chief Medical Officer, Andrew S. Kanter, MD, explores how the coronavirus pandemic has changed the plans for implementation and revealed gaps in the legislation.
Watch IMOs panel discussion with subject matter experts across the enterprise, who share insights on how the global pandemic is reshaping the health IT world.
Precise, comprehensive value sets can help identify specific patient cohorts for population health initiatives and quality reporting requirements. Find out how IMO Precision Acute Condition Sets can ease the burden of building and updating these powerful tools.
As the threat of COVID-19 continues to grow, so too does the urgent need for health IT solutions, like updated coding and terminology and telehealth services. To learn more about how the coronavirus pandemic is shaping the health IT space, IMO asked experts throughout the field to share their thoughts in our latest insight brief.
The first case of COVID-19 was confirmed in the United States on January 21, 2020. In the ensuing six months, the country has experienced a whirlwind of fear, confusion, and tragedy. We have also witnessed incredible strides in detection, treatment, and prevention of the disease. IMO’s Chief Medical Officer takes a look back at what we’ve learned and why there’s cause for optimism.
IMO’s latest product, IMO Precision Normalize, will help healthcare providers and the companies that support them to gain more accurate insights with a precise normalization engine that improves clinical, quality, and financial decision-making.
When it comes to COVID-19, we all have questions we want answered. But without reliable data and analytics, it’s a near impossible task, as illustrated by the challenges hospitals in the Midwest are now facing.